A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
Completed · Phase 1 · NCT06362265
Conditions: Type 2 Diabetes Mellitus
At a glance
- Research payments reported, 2025
- $502,247
- U.S. investigators named
- 10
- Sites paid
- 11
- Planned or actual enrollment
- 15
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- LY3209590 (drug)
- Dates
- Started 2024-10-10; completion 2026-01-02
- Results posted
- Not yet
The main purpose of this study is to evaluate how much of LY3209590 gets into the blood stream after a single dose and how long it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 days.
From ClinicalTrials.gov, last updated 2026-03-24. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $502,247 in research payments for this study in 2025 (21 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- James M. Swain, M.D. General Surgery · Scottsdale, AZ
- Lily C. Chao, MD Pediatric Endocrinology · Los Angeles, CA
- Kristina Cossen, MD Pediatric Endocrinology · Atlanta, GA
- Steven B. Leichter, M.D. Endocrinology & Diabetes · Columbus, GA
- Lori Michelle B. Laffel, M.D. Pediatric Endocrinology · Boston, MA
- Risa M. Wolf, M.D. Pediatric Endocrinology · Baltimore, MD
- Kathleen E. Bethin, MD Pediatric Endocrinology · Buffalo, NY
- Amy S. Shah, M.D. Pediatric Endocrinology · Cincinnati, OH
- Steven M. Willi, M.D. Pediatric Endocrinology · Philadelphia, PA
- Pedro Velasquez, MD Endocrinology & Diabetes · Memphis, TN
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Children's Hosp of Los Angeles, CA $111,081
- Johns Hopkins University $101,286
- Cincinnati Children's Hospital Medical Center, OH $85,506
- Childrens Healthcare of Atlanta $50,219
- Lifedoc Research PLLC $41,260
- Columbus Regional Research Institute LLC $34,787
- Children's Hospital of Philadelphia, PA $31,357
- Joslin Diabetes Center Inc $20,244
- Honor Health John C. Lincoln Medical Center, AZ $18,161
- Research Foundation of State Univ of Ny $7,944
- Columbus Clinical Research Inc $402
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.